|
Oct. 05, 2022 |
|
|
May. 22, 2023 |
|
|
jRCT1030220360 |
MDS-NMS TRANSLATION PROGRAM FOR NON-ENGLISH OFFICIAL VERSIONS |
|
MDS-NMS TRANSLATION PROGRAM |
Genko Oyama |
||
Neurology, Juntendo University |
||
2-1-1 Hongo, Bunkyo-ku, Tokyo |
||
+81-3-3813-3111 |
||
g_oyama@juntendo.ac.jp |
||
Yoshiyuki Matsuzaki |
||
Mebix Inc. |
||
10F. Toranomon 33 Mori Building 3-8-21 Toranomon, Minato-ku, Tokyo |
||
+81-3-4362-4500 |
||
MDS-NMS_validation-study@mebix.co.jp |
Complete |
Oct. 05, 2022 |
||
| June. 08, 2022 | ||
| 300 | ||
Observational |
||
Patients whose native language is Japanese |
||
Patients with serious underlying diseases or complications that make it difficult for the attending physician to make an evaluation decision. |
||
| No limit | ||
| No limit | ||
Both |
||
parkinson's disease |
||
D010300 |
||
Confirmatory factors for the 9 domains of MDS-NMS |
||
| Genko Oyama |
| International Congress of Parkinsons Disease and Movement Disorders | |
| Applicable |
| Research Ethics Committee, Faculty of Medicine, Juntendo University | |
| 2-1-1, Hongo, Bunkyo-ku, Tokyo, Tokyo, Tokyo | |
+81-3-5802-1584 |
|
| crbjun@juntendo.ac.jp | |
| Approval | |
May. 13, 2022 |
No |
none |